We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Corcept Therapeutics
CORT
$10.2B
| $64.7K | ﹤0.01% |
1,605
+328
| +26% | +$12.3K |
|
1577
Globalstar
GSAT
$10.2B
| $64.6K | ﹤0.01% |
973
+242
| +33% | +$14.8K |
|
1578
SentinelOne
S
$6.22B
| $64.4K | ﹤0.01% |
4,999
+1,111
| +29% | +$15.4K |
|
1579
Core Scientific
CORZ
$7.23B
| $64.3K | ﹤0.01% |
4,295
+944
| +28% | +$16.1K |
|
1580
Lemonade
LMND
$4.62B
| $64.2K | ﹤0.01% |
1,024
+200
| +24% | +$13.8K |
|
|
SARO
1581
StandardAero Inc
SARO
$9.54B
| $64.1K | ﹤0.01% |
2,482
+1,125
| +83% | +$33.6K |
|
1582
Ligand Pharmaceuticals
LGND
$6.02B
| $64.1K | ﹤0.01% |
321
+63
| +24% | +$12.5K |
|
|
CPRX
1583
DELISTED
Catalyst Pharmaceutical
CPRX
| $64.1K | ﹤0.01% |
2,588
+832
| +47% | +$19.8K |
|
1584
LCI Industries
LCII
$2.51B
| $64.1K | ﹤0.01% |
521
+152
| +41% | +$20.8K |
|
|
INVX
1585
Innovex International
INVX
$1.87B
| $63.9K | ﹤0.01% |
2,621
+584
| +29% | +$14.7K |
|
1586
Dana Inc
DAN
$2.91B
| $63.4K | ﹤0.01% |
1,884
+377
| +25% | +$11.8K |
|
1587
Howard Hughes
HHH
$3.93B
| $63.3K | ﹤0.01% |
1,001
+287
| +40% | +$21.5K |
|
1588
Freshpet
FRPT
$2.83B
| $63.2K | ﹤0.01% |
1,072
+280
| +35% | +$19.7K |
|
1589
CarGurus
CARG
$3.01B
| $63.2K | ﹤0.01% |
1,855
-1,634
| -47% | -$53.5K |
|
1590
Calix
CALX
$2.27B
| $63K | ﹤0.01% |
1,286
+342
| +36% | +$18K |
|
1591
Ondas Inc
ONDS
$4.44B
| $62.8K | ﹤0.01% |
+6,952
| New | +$75.6K |
|
1592
NMI Holdings
NMIH
$3.25B
| $62.6K | ﹤0.01% |
1,669
+407
| +32% | +$15.8K |
|
1593
CVB Financial
CVBF
$3.98B
| $62.6K | ﹤0.01% |
3,227
+1,019
| +46% | +$20K |
|
|
TPC
1594
Tutor Perini Cor
TPC
$4.57B
| $62.5K | ﹤0.01% |
810
+172
| +27% | +$13.2K |
|
1595
Westlake Corp
WLK
$9.46B
| $62.5K | ﹤0.01% |
535
+197
| +58% | +$19.1K |
|
1596
Olin
OLN
$2.64B
| $62.5K | ﹤0.01% |
2,101
+385
| +22% | +$9.41K |
|
1597
Integer Holdings
ITGR
$3.35B
| $62.4K | ﹤0.01% |
709
+142
| +25% | +$12.1K |
|
1598
Brink's
BCO
$5.02B
| $62.1K | ﹤0.01% |
599
-1,487
| -71% | -$178K |
|
|
NOAH
1599
Noah Holdings
NOAH
$588M
| $62.1K | ﹤0.01% |
6,268
+3,832
| +157% | +$44K |
|
1600
Cavco Industries
CVCO
$4.39B
| $62K | ﹤0.01% |
128
+27
| +27% | +$15.3K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.